PENNSYLVANIA ONCOLOGY HEMATOLOGY MANAGERS SOCIETY (EIN 251767622) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Principal Officer

CHERYL DOWNS

Phone

2157627026

Tax Period

2023-01-01 to 2023-12-31

PENNSYLVANIA ONCOLOGY HEMATOLOGY MANAGERS SOCIETY, founded in 1995, is a small nonprofit that reported $338K in total revenue in fiscal year 2023. Revenue decreased 18% compared to the prior year. Expenses of $397K exceeded revenue, resulting in a 18% operating deficit.

Mission

POHMS PROVIDES EDUCATION AND OPERATIONAL BEST PRACTICES TO HEMATOLOGY ONCOLOGY MEMBERS THROUGH PROFESSIONAL DEVELOPMENT AND NETWORKING. THE ORGANIZATION EMPOWERS MEMBERS BY CREATING AN ENVIRONMENT OF SUPPORT, COLLABORATION AND CONTINUOUS LEARNING.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $327,815

Investment Income $132

Other Revenue $9,738

TOTAL REVENUE $337,685

Expense Breakdown

Grants Paid $6,937

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $389,977

TOTAL EXPENSES $396,914

Year-over-Year Comparison

	2023	2022	Change
Revenue	$337,685	$412,852	-0.2%
Expenses	$396,914	$331,624	+0.2%
Net Income	$-59,229	$81,228	-1.7%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KAZEM SAHEBI	PRESIDENT	2.00	Officer Director	$0	$0	$0
AJ CORDERO	VICE PRESIDENT	2.00	Officer Director	$0	$0	$0
CLARK BETYN	BOARD MEMBER	2.00	Director	$0	$0	$0
ANGELA LYNCH	BOARD MEMBER	2.00	Director	$0	$0	$0
KIM DISTASIO	SECRETARY	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$337,685	$396,914	$763,009	$-59,229
2022	$412,852	$331,624	$837,237	$81,228
2021	$308,524	$192,172	$756,009	$116,352
2020	$272,603	$233,151	$639,657	$39,452
2019	$277,651	$284,360	$600,205	$-6,709
2018	$348,726	$275,060	$606,915	$73,666

PENNSYLVANIA ONCOLOGY HEMATOLOGY MANAGERS SOCIETY